Use of selective serotonin reuptake inhibitors guided by pharmacogenetic testing may improve treatment response in depression
1. Genotype-guided prescribing of selective serotonin reuptake inhibitors (SSRIs) may improve treatment response in children and adults with depression. Evidence ...